At Acumen, we’re developing targeted Alzheimer’s disease treatments for patients to hold onto their moments – and to create new ones.
How does ACU193 work?
We are advancing ACU193, a therapy targeting AβO and designed to have disease-modifying benefits with an improved safety profile, while also potentially providing symptomatic benefit for Alzheimer’s patients.